Daniel Elbirt
Impact in
- Virology top 5%
- HIV Research and Treatment
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
Papers in
- Virology 15
- HIV Research and Treatment 15
-
- HIV/AIDS Research and Interventions 16
- HIV/AIDS drug development and treatment 11
- Co-authors
- Zev SthoegerIlan AsherKeren Mahlab‐GuriMenachem RubinsteinDaniela NovickCharles A. DinarelloEdna MozesMia Levite
- Journals
- International Journal of STD & AIDS (4 papers)Medicine (3 papers)HIV Medicine (2 papers)Journal of the International AIDS Society (2 papers)Pediatric Allergy and Immunology (2 papers)
- Partner nations
- IsraelSpainUnited States
In The Last Decade
Daniel Elbirt
48 papers receiving 707 citations
Peers
Comparison fields: 5 of 84
- Virology 131
- Rheumatology 194
- Immunology 217
- Infectious Diseases 170
- Emergency Medicine 79
Countries citing papers authored by Daniel Elbirt
This map shows the geographic impact of Daniel Elbirt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Elbirt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Elbirt more than expected).
Fields of papers citing papers by Daniel Elbirt
This network shows the impact of papers produced by Daniel Elbirt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Elbirt. The network helps show where Daniel Elbirt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Elbirt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 7 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 1 | |
| 12 | Anti-BLyS Treatment of 36 Israeli Systemic Lupus Erythematosus Patients. | 2017 | 13 |
| 13 | 2017 | 7 | |
| 14 | 2016 | 14 | |
| 15 | 2015 | 40 | |
| 16 | 2014 | 17 | |
| 17 | 2011 | 26 | |
| 18 | The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE study. | 2007 | 12 |
| 19 | 2006 | 11 | |
| 20 | 2002 | 37 |
About Daniel Elbirt
Daniel Elbirt is a scholar working on Virology, Infectious Diseases, Immunology and Allergy, Emergency Medicine and Rheumatology, having authored 51 papers that have together received 717 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (16 papers), HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (11 papers), Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), HIV-related health complications and treatments (8 papers), T-cell and B-cell Immunology (6 papers) and Allergic Rhinitis and Sensitization (3 papers). The work is most often cited by research in Virology (131 citations), Rheumatology (194 citations), Immunology (217 citations), Infectious Diseases (170 citations) and Emergency Medicine (79 citations). Daniel Elbirt has collaborated with scholars based in Israel, Spain and United States. Frequent co-authors include Zev Sthoeger, Ilan Asher, Keren Mahlab‐Guri, Menachem Rubinstein, Daniela Novick, Charles A. Dinarello, Edna Mozes, Mia Levite, Molly Dayan and Eystein S. Husebye. Their work appears in journals such as International Journal of STD & AIDS, Medicine, HIV Medicine, Journal of the International AIDS Society and Pediatric Allergy and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.